Page last updated: 2024-12-05

deet

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-diethyl-m-toluamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of m-toluic acid with the nitrogen of diethylamine. First developed by the U.S. Army in 1946 for use by military personnel in insect-infested areas, it is the most widely used insect repellent worldwide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4284
CHEMBL ID1453317
CHEBI ID7071
SCHEMBL ID29976
MeSH IDM0005744

Synonyms (181)

Synonym
off!
n,n-diethyl-3-methyl-benzamide
m-toluamide, n,n-diethyl-
a.i. 3-22542
wln: 2n2 & vr c1
m-deta
deta-20
dieltamid
OFF ,
m-toluic acid diethylamide
ent 22542
m-delphene
flypel
3-methyl-n,n-diethylbenzamide
diethyl-m-toluamide
delphene
autan
metadelphene
ent 20,218
m-toluamide,n-diethyl-
m-det
nsc-33840
benzamide,n-diethyl-3-methyl-
nsc33840
detamide
naugatuck det
n,n-diethyl-3-methylbenzamide
repper-det
repudin-special
DIVK1C_000157
KBIO1_000157
SPECTRUM_001989
SPECTRUM5_002076
benzamide, n,n-diethyl-3-methyl-
(n,n-diethyltoluamide)
MLS001333179
NCGC00091219-01
brn 2046711
einecs 205-149-7
ai 3-22542
nsc 33840
amincene c-em
repper det
bepper det
n,n-diethyl-meta-toluamide and other isomers
n,n-diethyl-meta-toluamide
dietiltoluamida [inn-spanish]
muscol
amincene c 140
hsdb 1582
epa pesticide chemical code 080301
det (insect repellant)
diethyl toluamide
repel
mgk diethyltoluamide
ccris 6018
caswell no. 346
diethyltoluamidum [inn-latin]
134-62-3
diethyltoluamide
DEET ,
n,n-diethyl-m-toluamide
deet, analytical standard
n,n-diethyl-m-toluamide, analytical standard
n,n-diethyl-3-methylbenzamide, 97%
diethyltoluamide (usp/inn)
D02379
IDI1_000157
NCGC00091219-02
NCGC00091219-03
KBIO2_002546
KBIO2_007682
KBIOSS_002555
KBIO2_005114
KBIOGR_000798
SPECTRUM4_000439
NINDS_000157
SPBIO_001084
SPECTRUM2_001072
SPECTRUM1601020
NCGC00091219-04
n,n diethyl 3 methylbenzamide
n,n diethyltoluamide
n,n diethyl m toluamide
MLS001333180
smr000777931
AC-11315
HMS2094E11
D0097
MLS002207091
MLS002415750
HMS500H19
FT-0665567
AKOS003852835
NCGC00091219-05
NCGC00091219-06
n,n-diethyl 3-methyl benzamide
ent-20218
deet n,n-diethyl-meta-toluamide
chebi:7071 ,
CHEMBL1453317
oristar deet
ent-22542
diethyltoluamidum
de3 ,
tox21_300917
NCGC00254820-01
tox21_201980
NCGC00259529-01
pharmakon1600-01601020
nsc759564
nsc-759564
dtxsid2021995 ,
tox21_111103
dtxcid601995
cas-134-62-3
HMS2231H11
S4521
fb0c1xzv4y ,
unii-fb0c1xzv4y
diethyltoluamide [usp:inn:ban]
dietiltoluamida
FT-0629479
deet n,n-diethyl-meta-toluamide [vandf]
diethyltoluamidum [who-ip latin]
diethyltoluamide [who-ip]
diethyltoluamide [hsdb]
diethyltoluamide [usp monograph]
deet [mi]
diethyl toluamide [inci]
diethyltoluamide [mart.]
diethyltoluamide [who-dd]
diethyltoluamide [usp-rs]
diethyltoluamide [inn]
HMS3372F07
CCG-213639
SCHEMBL29976
tox21_111103_1
3N7H
NCGC00091219-08
CS-4468
n,n-diethyl m-toluamide
Q-200984
HY-B0978
AB00052406_06
mfcd00009046
Z31723661
sr-05000001887
SR-05000001887-1
diethyltoluamide, united states pharmacopeia (usp) reference standard
deet, pestanal(r), analytical standard
deet 10 microg/ml in methanol
deet 100 microg/ml in methanol
SBI-0051886.P002
Q408389
deet-(diethyl-d10)
n-diethyl-meta-toluamide
DB11282
DS-13831
deet;n,n-diethyl-m-toluamide
n,n-diethyl-3-methyl-d3-benzamide--d4
BRD-K94080537-001-05-5
SY048762
DTXSID001014729 ,
EN300-15589
dietiltoluamida (inn-spanish)
p03bx01
diethyltoluamide (usp:inn:ban)
diethyltoluamidum (inn-latin)
deet-di ethyl toluamide
pesticide code: 080301
insect repellent insect block
diethyltoluamide (usp monograph)
diethyltoluamide (mart.)
mosquito bug off
n,n-diethyl-m-methylbenzamide
ent 22,542
ent 20218
n,n-diethyl-m-tolylamide
diethyltoluamide (usp-rs)
diethyltoluamidum (latin)

Research Excerpts

Overview

DEET is a mild, while chlorpyrifos is a relatively potent, inducer of adenylate kinase and caspase-3/7. The DEET Registry is a post-marketing surveillance system to provide systematic and detailed information about medical events temporally associated with DEET use.

ExcerptReferenceRelevance
"DEET is a mild, while chlorpyrifos is a relatively potent, inducer of adenylate kinase and caspase-3/7, an indicator of apoptosis, while inducing 15-20% and 25-30% cell death, respectively."( Enzyme induction and cytotoxicity in human hepatocytes by chlorpyrifos and N,N-diethyl-m-toluamide (DEET).
Cao, Y; Cherrington, N; Das, PC; Hodgson, E; Rose, RL, 2008
)
1.28
"The DEET Registry is a post-marketing surveillance system to provide systematic and detailed information about medical events temporally associated with DEET use."( Adverse events associated with the use of insect repellents containing N,N-diethyl-m-toluamide (DEET).
Fell, LA; Murphy, JV; Osimitz, TG; Page, B, 2010
)
1.06
"DEET showed to be a weak and reversible inhibitor of hAChE and hBChE."( In vitro kinetic interactions of DEET, pyridostigmine and organophosphorus pesticides with human cholinesterases.
Thiermann, H; Wille, T; Worek, F, 2011
)
1.37
"DEET MC is a formulation of DEET (N,N diethyl-m-toluamide) in which the repellent is gradually released from a capsule that binds the repellent."( DEET microencapsulation: a slow-release formulation enhancing the residual efficacy of bed nets against malaria vectors.
Knols, BG; N'guessan, R; Pennetier, C; Rowland, M, 2008
)
2.51
"DEET is a safe and effective repellent."( Safety and efficacy of DEET and permethrin in the prevention of arthropod attack.
Evans, S; Young, GD, 1998
)
1.33

Effects

DEET has an excellent safety profile and has remarkable protection against mosquitoes, ticks and various other arthropods. DEET has a dose-dependent repellent activity on B. candida.

DEET has proven to be the most effective repellent against Dermacentor reticulatus ticks. DEET has an excellent safety profile and remarkable protection against mosquitoes and various other arthropods.

ExcerptReferenceRelevance
"DEET has an excellent safety profile and remarkable protection against mosquitoes and various other arthropods."( Insect repellents: An updated review for the clinician.
Hebert, AA; Nguyen, QD; Vu, MN, 2023
)
1.63
"DEET has an excellent safety profile and has remarkable protection against mosquitoes, ticks and various other arthropods."( Bug off! Severe toxicity following inhalational exposure to N, N-diethyl-meta-toluamide (DEET).
Jones, JS; Judge, BS; Tavares, EM, 2019
)
1.46
"DEET has a dose-dependent repellent activity on B."( Locomotor behaviour of Blattella germanica modified by DEET.
Alzogaray, RA; Mougabure-Cueto, GA; Sfara, V; Zerba, EN, 2013
)
1.36
"DEET has been more extensively studied for safety than any other repellent, and is accepted as completely safe when used correctly (i.e."( Who's afraid of DEET? Fearmongering in papers on botanical repellents.
Shelomi, M, 2020
)
1.63
"DEET has an excellent safety profile and remarkable protection against mosquitoes and various other arthropods."( Insect repellents: An updated review for the clinician.
Hebert, AA; Nguyen, QD; Vu, MN, 2023
)
1.63
"DEET has an excellent safety profile and has remarkable protection against mosquitoes, ticks and various other arthropods."( Bug off! Severe toxicity following inhalational exposure to N, N-diethyl-meta-toluamide (DEET).
Jones, JS; Judge, BS; Tavares, EM, 2019
)
1.46
"DEET has proven to be the most effective repellent against Dermacentor reticulatus ticks."( Susceptibility of Dermacentor reticulatus tick to repellents containing different active ingrediens
Borecka, A; Gliniewicz, A; Mikulak, E; Przygodzka, M, 2019
)
1.96
"DEET has a dose-dependent repellent activity on B."( Locomotor behaviour of Blattella germanica modified by DEET.
Alzogaray, RA; Mougabure-Cueto, GA; Sfara, V; Zerba, EN, 2013
)
1.36
"DEET has reigned as the most efficacious and broadly used IR for the last 6 decades, with a strong safety record and excellent protection against ticks, mosquitoes, and other arthropods."( Insect repellents: historical perspectives and new developments.
Hebert, AA; Katz, TM; Miller, JH, 2008
)
1.07

Treatment

The deet-treated jacket provided 87-93% protection. Mice treated with DEET demonstrated induced levels of the CYP2B family. Treatment for DEET toxicosis includes symptomatic therapy and decontamination.

ExcerptReferenceRelevance
"The deet-treated jacket provided 87-93% protection."( Insect repellent jacket tests against biting midges (diptera: Culicoides) in Panama.
Harlan, HJ; Kline, DL; Schreck, CE, 1983
)
0.75
"Deet-treated net jackets also provided good protection, but it was concluded that an additional application of repellent to the unprotected face was necessary for maximum protection."( Evaluation of personal protection methods against phlebotomine sand flies including vectors of leishmaniasis in Panama.
Chaniotis, BN; Kline, DL; McGovern, TP; Schreck, CE; Weidhaas, DE; Wilkinson, N, 1982
)
0.99
"Treatment with DEET or permethrin alone, malathion and permethrin, or DEET and permethrin produced significant increases in cortical acetylcholinesterase (AChE) activity."( Neurological deficits induced by malathion, DEET, and permethrin, alone or in combination in adult rats.
Abdel-Rahman, A; Abou-Donia, MB; Bullman, SH; Dechkovskaia, AM; El-Masry, EM; Goldstein, LB; Khan, W, 2004
)
0.92
"Mice treated with DEET demonstrated induced levels of the CYP2B family, increased hydroxylation, and a 2.4-fold increase in the metabolism of chlorpyrifos to chlorpyrifos-oxon, a potent anticholinesterase."( In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide.
Brimfield, AA; Goldstein, JA; Hodgson, E; Rose, RL; Taylor, WG; Usmani, KA, 2002
)
0.64
"Treatment for DEET toxicosis includes symptomatic therapy and decontamination."( Diethyltoluamide (DEET) insect repellent toxicosis.
Dorman, DC, 1990
)
0.96

Toxicity

The risk of serious neurological events following the use of DEET repellents is quite low. Results suggest that DEET may have some toxic actions that are similar to those of formamidine pesticides.

ExcerptReferenceRelevance
" Important information about deet also comes from an investigation into the reports of adverse affects reported to 71 poison control centers in the USA."( The present safety assessment of deet.
Grothaus, RH; Osimitz, TG, 1995
)
0.86
" We hypothesize that test compounds may compete for xenobiotic metabolizing enzymes in the liver and blood and may also compromise the integrity of the blood-brain barrier, leading to an increase in their "effective concentrations" in the nervous system to levels equivalent to the toxic doses of individual compounds."( Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos.
Abdel-Rahman, AA; Abou-Donia, MB; Jensen, KF; Kurt, TL; Oehme, FW; Wilmarth, KR, 1996
)
0.52
" DEET is a safe and effective repellent."( Safety and efficacy of DEET and permethrin in the prevention of arthropod attack.
Evans, S; Young, GD, 1998
)
1.52
" As evidenced by over 4 decades of human experience and rigorous animal testing, deet is generally safe for topical use if applied as recommended, although it has occasionally been related to side effects such as toxic encephalopathy, seizure, acute manic psychosis, cardiovascular toxicity, and dermatitis, along with a few cases of death due to extensive skin absorption."( Pharmacokinetics, formulation, and safety of insect repellent N,N-diethyl-3-methylbenzamide (deet): a review.
Jun, HW; McCall, JW; Qiu, H, 1998
)
0.75
" The objective of this study was to test the hypothesis that the potential toxicity of DEET is high and that available repellents containing DEET, irrespective of their strength, are not safe when applied to children's skin."( Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children.
Briassoulis, G; Hatzis, T; Narlioglou, M, 2001
)
0.79
" No adverse neurologic, gastrointestinal, or dermatologic effects were observed for women who applied a median total dose of 214."( Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy.
Cho, T; Edwards, R; Hamilton, KA; Lindsay, SW; Looareesuwan, S; Luxemburger, C; McGready, R; Nosten, F; Simpson, JA; White, NJ, 2001
)
0.56
" However, concerns have been raised over the risk of adverse toxic effects, especially in young children and pregnant and lactating women."( DEET-based insect repellents: safety implications for children and pregnant and lactating women.
Bailey, B; Koren, G; Matsui, D, 2003
)
1.76
" This article describes those changes, and summarizes more recent data relating to the pharmacokinetics, toxicology, and epidemiology of adverse effects associated with DEET in humans."( DEET: a review and update of safety and risk in the general population.
Sudakin, DL; Trevathan, WR, 2003
)
1.96
" An effective and safe repellent will be useful in reducing human-vector contact and thereby help in the interruption of vector borne disease transmission."( N,N-diethyl phenylacetamide (DEPA): A safe and effective repellent for personal protection against hematophagous arthropods.
Kalyanasundaram, M; Mathew, N, 2006
)
0.33
" Outcomes Included physical performance (handgrip strength and duration, stair climbing, and pull-ups [males] or push-ups [females]), neurocognitive performance (computerized tests), and self-reported adverse effects."( Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.
Cantilena, LR; Chang, DN; Cherstniakova, SA; Cooper, JA; Deuster, PA; Kamens, DR; Krantz, DS; Kraus, PL; Law, WA; Matulich, W; Roy, MJ; Sato, PA; Seegers, CA; Young, SY, 2006
)
0.33
" Physical and neurocognitive outcome measures and self-reported adverse effects did not significantly differ by exposure group."( Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.
Cantilena, LR; Chang, DN; Cherstniakova, SA; Cooper, JA; Deuster, PA; Kamens, DR; Krantz, DS; Kraus, PL; Law, WA; Matulich, W; Roy, MJ; Sato, PA; Seegers, CA; Young, SY, 2006
)
0.33
" Results suggest that DEET may have some toxic actions that are similar to those of formamidine pesticides."( Synergism of toxicity of N,N-diethyl-m-toluamide to German cockroaches (Orthoptera: Blattellidae) by hydrolytic enzyme inhibitors.
Moss, JI, 1996
)
0.61
" The acute dermal LD50 was > 5000 mg/kg BW."( Efficacy and safety of catnip (Nepeta cataria) as a novel filth fly repellent.
Berkebile, D; DU, HJ; Qian, K; Tong, Y; Zeng, XP; Zhu, JJ, 2009
)
0.35
" Recognizing the extensive use of DEET in the US and considering the information about the more serious adverse events described in the Registry, the risk of serious neurological events following the use of DEET repellents is quite low."( Adverse events associated with the use of insect repellents containing N,N-diethyl-m-toluamide (DEET).
Fell, LA; Murphy, JV; Osimitz, TG; Page, B, 2010
)
0.86
" Measured concentrations of DEET in surface waters are several hundreds to thousands of times lower than the lowest NOEC measured, and thus the probability for adverse effects to environmental species is low."( Assessment of the environmental fate and ecotoxicity of N,N-diethyl-m-toluamide (DEET).
Guiney, PD; Nikiforov, AI; Weeks, JA, 2012
)
0.9
" Animal testing, observational studies and intervention trials have found no evidence of severe adverse events associated with recommended DEET use."( Assessment of methods used to determine the safety of the topical insect repellent N,N-diethyl-m-toluamide (DEET).
Behrens, R; Chen-Hussey, V; Logan, JG, 2014
)
0.82
"69 microg/cm2) were the most toxic compounds, followed by methyl eugenol (5."( Toxicity of basil oil constituents and related compounds and the efficacy of spray formulations to Dermatophagoides farinae (Acari: Pyroglyphidae).
Ahn, YJ; Hwang, KN; Kim, JR; Kim, JY; Perumalsamy, H, 2014
)
0.4
" Although a widely used and extremely safe insect repellent, DEET can be highly toxic in large but easily obtainable doses."( A lethal case of DEET toxicity due to intentional ingestion.
Casavant, M; Castillo, U; Russell, J; Spiller, H; Wiles, D; Yee, J,
)
0.71
" Although toxic to mosquitoes (LD50 ca."( Neurotoxicity and mode of action of N, N-diethyl-meta-toluamide (DEET).
Bloomquist, JR; Sun, B; Swale, DR; Tong, F, 2014
)
0.64
" Based on these data, this review provides new insights on side effects in human and more largely in mammals by identifying the unusual properties of DEET in insects, which seem to be correlated with adverse effects in mammals."( Unusual modes of action of the repellent DEET in insects highlight some human side effects.
Apaire-Marchais, V; Clere, N; Faure, S; Lapied, B; Legeay, S, 2018
)
0.95
"6 µg/g was the most toxic natural compound followed by 1-octanol (LC50 = 486."( Toxicity and Repellency of Magnolia grandiflora Seed Essential Oil and Selected Pure Compounds Against the Workers of Hybrid Imported Fire Ants (Hymenoptera: Formicidae).
Ali, A; Chen, J; Khan, IA, 2022
)
0.72
" The results showed that Solid Lipid Microparticles are safe and promising topical formulation to insect bite prevention."( Microencapsulation of DEET in Solid Lipid Microparticles: production, characterization and safety evaluation.
Ricci-Junior, E; Santos, PA; Silva, MRMD; Tavares, M, 2022
)
1.04

Pharmacokinetics

Model-independent pharmacokinetic methods based on statistical moments were applied to investigate the plasma disposition characteristics of N,N-diethyl-m-toluamide. After single-dose treatment of experimental cattle by rapid intravenous injection (2.5 mg/kg), plasma DEET concentrations declined biexponentially. Concurrent application of DEET and permethrin induced urinary excretion of 3-nitrotyrosine and 8-hydroxy-2'-deoxyguanosine, markers of DNA damage and oxidative stress in rats.

ExcerptReferenceRelevance
"Model-independent pharmacokinetic methods based on statistical moments were applied to investigate the plasma disposition characteristics of N,N-diethyl-m-toluamide (DEET insect repellent) after single-dose treatment of experimental cattle by rapid intravenous injection (2."( Pharmacokinetic assessment of the dermal absorption of N,N-diethyl-m-toluamide (DEET) in cattle.
Danielson, TJ; Golsteyn, LR; Spooner, RW; Taylor, WG,
)
0.55
" Concurrent application of DEET and permethrin induced urinary excretion of 3-nitrotyrosine and 8-hydroxy-2'-deoxyguanosine, markers of DNA damage and oxidative stress in rats, increased the release of rat brain mitochondrial cytochrome c, disrupted the blood-brain barrier (BBB) in rats, decreased m2 muscarinic acetylcholine receptor ligand binding density in rat brain, increased urinary excretion of 6 beta-hydroxycortisol, a marker CYP3A4 induction, altered sensorimotor and locomotor activities in rats, and changed in vivo and in vitro metabolism and pharmacokinetic profiles of the individual compound."( Combined exposure to DEET (N,N-diethyl-m-toluamide) and permethrin: pharmacokinetics and toxicological effects.
Abou-Donia, MB; Abu-Qare, AW,
)
0.75

Compound-Compound Interactions

ExcerptReferenceRelevance
" A single dermal dose of DEET alone and in combination with permethrin significantly increased urinary excretion of 6beta-hydroxycortisol 24 h after dosing."( DEET (N,N-diethyl-m-toluamide) alone and in combination with permethrin increased urinary excretion of 6beta-hydroxycortisol in rats, a marker of hepatic CYP3A induction.
Abou-Donia, MB; Abu-Qare, AW, 2001
)
2.06
" An in vitro cell-resistant assay was used to monitor the potential of test compounds to interact with P-gp."( Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant.
Abou-Donia, MB; El-Masry, EM, 2006
)
0.33

Bioavailability

The DEET transdermal bioavailability and mean absorption time were 18. At 15 mg DEE, a 3-fold reduction in the amount of deet absorbed. This conclusion explains, at least in part, the increased toxicity and bioavailability of pyridostigmine bromide following combined administration with DEET.

ExcerptReferenceRelevance
" Both the extent and rate of absorption in monkeys were highly dependent on anatomic site, with 14 +/- 5% (t1/2 = 4 h) penetrating the forearm, 33 +/- 11% (t1/2 = 6 h) the forehead, 27 +/- 3% (t1/2 = 7 h) the dorsal forepaw, and 68 +/- 9% (t1/2 = 8 h) the ventral forepaw."( Dermal absorption of the insect repellent DEET (N,N-diethyl-m-toluamide) in rats and monkeys: effect of anatomical site and multiple exposure.
Benoit, FM; Moody, RP; Riedel, D; Ritter, L, 1989
)
0.54
" The bioavailability of deet from 10% ethanol solution was 45%, whereas the bioavailability of deet from lipospheres was 16%, a 3-fold reduction in the amount of deet absorbed."( Insect repellent formulations of N,N-diethyl-m-toluamide (deet) in a liposphere system: efficacy and skin uptake.
Domb, AJ; Maniar, M; Marlinsky, A; Teomim, L, 1995
)
0.84
" The rate of absorption and subsequent excretion of administered radioactivity into the urine and feces was much slower after dermal administration than after all oral dosing regimens."( Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Hartnagel, RE; Llanso, S; Osimitz, TG; Schoenig, GP, 1996
)
0.29
" The DEET transdermal bioavailability and mean absorption time were 18."( Pharmacokinetics of insect repellent N,N-diethyl-m-toluamide in beagle dogs following intravenous and topical routes of administration.
Jun, HW; Qiu, H; Tao, J, 1997
)
0.81
" At 15 mg DEET/kg, the absolute DEET transdermal bioavailability and Cmax were 13."( Reduced transdermal absorption of N,N-diethyl-m-toluamide from a new topical insect repellent formulation.
Dzimianski, M; Jun, HW; McCall, J; Qiu, H, 1997
)
0.7
" This conclusion explains, at least in part, the increased toxicity and bioavailability of pyridostigmine bromide following combined administration with DEET."( Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant.
Abou-Donia, MB; El-Masry, EM, 2006
)
0.53
" The objective of this study was to determine whether the skin absorption rate of DEET could be decreased while maintaining an evaporation rate consistent with effective repellency."( Microencapsulation decreases the skin absorption of N,N-diethyl-m-toluamide (DEET).
Bhatt, VD; Kasting, GB; Speaker, TJ, 2008
)
0.8
" Due to differences in the dermal absorption of DEET between mice and humans, this study eliminated this confounding factor by utilizing sc injection and measured circulating blood levels of DEET to assess bioavailability from sc administration."( N,N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice.
Dudley, AC; EuDaly, JG; Gilkeson, GS; Keil, DE; McGuinn, WD; Peden-Adams, MM, 2009
)
0.91
" In addition, DEET inhibited AChE which increased acetylcholine bioavailability and binding to M3 receptors and also strengthened proangiogenic effects by an allosteric modulation."( The insect repellent N,N-diethyl-m-toluamide (DEET) induces angiogenesis via allosteric modulation of the M3 muscarinic receptor in endothelial cells.
Apaire-Marchais, V; Bernard, P; Clere, N; Do, QT; Faure, S; Hilairet, G; Lapied, B; Legeay, S; Quignard, JF, 2016
)
1.05
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

IPPSFs (n=4/treatment) were topically dosed with mixtures of permethrin, DEET, andpermethrin/DEET, in ethanol. No significant differences of protection were observed between the three repellent treatments. The rate of DEET degradation increased exponentially with temperature in the range studied (20-50 degrees C) and in proportion with the dosage of ozone applied.

ExcerptRelevanceReference
" Cloth treated with Quwenling at greater than 2x the dosage of deet was effective against 2 of 4 species tested (Ae."( Efficacy assessment of Quwenling, a mosquito repellent from China.
Leonhardt, BA; Schreck, CE, 1991
)
0.52
" stephensi Liston, using a "free choice," dose-response testing procedure on rabbits."( Comparative sensitivity of four Anopheles (Diptera: Culicidae) to five repellents.
Hallam, JA; Robert, LL; Roberts, LW; Seeley, DC; Wirtz, RA, 1991
)
0.28
" No significant differences of protection were observed between the three repellent treatments, although the two controlled-release formulations (intended to be more persistent) were applied at approximately half the dosage of the standard 75% deet."( Evaluations of permethrin-impregnated clothing and three topical repellent formulations of deet against tsetse flies in Zambia.
Mwangelwa, MI; Nondo, J; Schreck, CE; Sholdt, LL; Siachinji, VJ, 1989
)
0.68
"Three topical repellents were evaluated against Phlebotomus perniciosus using dose-response techniques."( Laboratory tests of three repellents against Phlebotomus perniciosus (Diptera:Psychodidae).
Fossati, FP; Maroli, M, 1986
)
0.27
" The total percent urinary 14C recovery was significantly higher in rats dosed with F-A (73."( The effect of DEET (N,N-diethyl-m-toluamide) on dermal persistence and absorption of the insecticide fenitrothion in rats and monkeys.
Franklin, CA; Moody, RP; Riedel, D; Ritter, L, 1987
)
0.63
" Rats were administered undiluted DEET by gavage on Gestational Days (gd) 6-15 at dosage levels of 0, 125, 250, and 750 mg/kg/day."( Teratologic evaluations of N,N-diethyl-m-toluamide (DEET) in rats and rabbits.
Fisher, LC; Hartnagel, RE; Neeper-Bradley, TL; Schoenig, GP, 1994
)
0.82
" An apparent treatment-related effect in thermal response time (increased) was noted for both sexes 1 hr after dosing at the 500 mg/kg dose level."( Neurotoxicity evaluation of N,N-diethyl-m-toluamide (DEET) in rats.
Hartnagel, RE; Schardein, JL; Schoenig, GP; Vorhees, CV, 1993
)
0.54
" stephensi Liston, and Phlebotomus papatasi (Scopoli) using a dose-response testing procedure on human volunteers."( Laboratory evaluation of repellents against four anopheline mosquitoes (Diptera: Culicidae) and two phlebotomine sand flies (Diptera: Psychodidae).
Coleman, RE; Glass, JA; Laughinghouse, A; Perkins, PV; Robert, LL; Roberts, LW; Seeley, DC; Wirtz, RA, 1993
)
0.29
" The major urinary metabolites were identified, and the urinary metabolic profile for each dosage regimen was determined."( Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Hartnagel, RE; Llanso, S; Osimitz, TG; Schoenig, GP, 1996
)
0.29
" Phase I determined the acute oral lethal dose-response relationship of each compound with the vehicle, propylene glycol."( Acute oral toxicity study of pyridostigmine bromide, permethrin, and DEET in the laboratory rat.
Beall, P; Ferguson, JW; Johnson, MS; Leach, G; Lee, R; McCain, WC; Whaley, JE, 1997
)
0.53
" Dosing solutions were also prepared with either acetone, dimethyl sulfoxide (DMSO), or ethanol to compare vehicle effects on percutaneous absorption of permethrin and DEET."( The influence of diethyl-m-toluamide (DEET) on the percutaneous absorption of permethrin and carbaryl.
Baynes, RE; Halling, KB; Riviere, JE, 1997
)
0.76
" DEET was mixed in the diet and administered to CD rats for two years at concentrations that corresponded to dosage levels of 10, 30 or 100 mg/kg/day for males and 30, 100, or 400 mg/kg/day for females; to CD-1 mice for 18 months at dosage levels of 250, 500, or 1000 mg/kg/day; and to dogs for one year, via gelatin capsules, at dosage levels of 30, 100, or 400 mg/kg/day."( Evaluation of the chronic toxicity and oncogenicity of N,N-diethyl-m-toluamide (DEET).
Gabriel, KL; Gill, MW; Goldenthal, EI; Hartnagel, R; Osimitz, TG; Schoenig, GP, 1999
)
1.44
" Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males."( Pyridostigmine bromide alters locomotion and thigmotaxis of rats: gender effects.
Cody, BA; Hoy, JB; Karlix, JL; Schmidt, CJ; Tebbett, IR; Toffollo, S; Van Haaren, F; Wielbo, D, 1999
)
0.3
" The insect repellent N,N-diethyl-m-toluamide (DEET) reduced the TSP protection against HD regardless of the order of application on rabbit skin prior to dosing of HD."( Efficacy of the topical skin protectant in advanced development.
Hayes, TL; Liu, DK; Snider, TH; Wannemacher, RW, 1999
)
0.56
" The bioassay system is calibrated with diethyl methylbenzamide against Aedes aegypti and demonstrates a reproducible dose-response relationship."( A wind tunnel bioassay system for screening mosquito repellents.
Copland, MJ; Healy, TP; Sharpington, PJ, 2000
)
0.31
"05) increased levels of 3-nitrotyrosine starting 24 h after dosing compared with control urine samples."( Induction of urinary excretion of 3-nitrotyrosine, a marker of oxidative stress, following administration of pyridostigmine bromide, DEET (N,N-diethyl-m-toluamide) and permethrin, alone and in combination in rats.
Abou-Donia, MB; Abu-Qare, AW; Suliman, HB, 2001
)
0.51
" IPPSFs (n=4/treatment) were topically dosed with mixtures of permethrin, DEET, and permethrin/DEET, in ethanol."( Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin.
Baynes, RE; Monteiro-Riviere, NA; Riviere, JE, 2003
)
0.55
" DEET absorption was enhanced by coinfusion of pyridostigmine bromide and DFP, by the presence of sulfur mustard, or by dosing under complete occlusion."( Percutaneous absorption of topical N,N-diethyl-m-toluamide (DEET): effects of exposure variables and coadministered toxicants.
Baynes, RE; Brooks, JD; Monteiro-Riviere, NA; Riviere, JE; Yeatts, JL, 2003
)
1.47
" In two experiments using Aedes aegypti, one using a single identical dose and one with varying doses used to develop a dose-response curve, SS220 was as effective as Deet and both compounds were more effective than Bayrepel."( Synthesis and repellent efficacy of a new chiral piperidine analog: comparison with Deet and Bayrepel activity in human-volunteer laboratory assays against Aedes aegypti and Anopheles stephensi.
Debboun, M; Khrimian, A; Klun, JA; Kramer, M; Margaryan, A, 2003
)
0.74
" We investigated the dose-response effects of these chemicals, alone or in combination, on the sensorimotor performance and cholinergic system of male Sprague-Dawley rats."( Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity.
Abdel-Rahman, A; Abou-Donia, MB; Bullman, SL; Dechkovskaia, AM; Goldstein, LB; Khan, WA, 2004
)
0.59
" According to a logistic regression model fitted to the experimental data, the dose-response relationship for the two repellents was the same within each species, thus pooled ED values were assessed for each mosquito separately."( Evaluation of the sensitivity of Aedes aegypti and Anopheles gambiae complex mosquitoes to two insect repellents: DEET and KBR 3023.
Badolo, A; Costantini, C; Ilboudo-Sanogo, E; Ouédraogo, AP, 2004
)
0.53
" For each compound, in vitro dose-response assays were conducted with compounds applied to cloth positioned over blood reservoirs covered with Baudruche membrane against Aedes aegypti."( A new in vitro bioassay system for discovery of novel human-use mosquito repellents.
Debboun, M; Klun, JA; Kramer, M, 2005
)
0.33
"7 mg of product/cm2, the latter dosage being the industrial standard for deet based repellents."( Efficacy of repellent products against caged and free flying Anopheles stephensi mosquitoes.
Curtis, CF; Rongsriyam, Y; Trongtokit, Y, 2005
)
0.56
" Enhancement ratios were higher at 24 h for 10 than for 6 g/kg animals, demonstrating a dose-response relationship for recovery time."( A single oral dose of ethanol can alter transdermal absorption of topically applied chemicals in rats.
Brand, RM; Charron, AR; Henery, EM; Jendrzejewski, JL, 2006
)
0.33
" I began with pretrial studies of dosing behavior to compute formula-specific mean dosing rates for the subsequent efficacy trials."( Prolonged efficacy of IR3535 repellents against mosquitoes and blacklegged ticks in North America.
Carroll, SP, 2008
)
0.35
" The rate of DEET degradation increased exponentially with temperature in the range studied (20-50 degrees C) and in proportion with the dosage of ozone applied."( Degradation of DEET by ozonation in aqueous solution.
Abas, MR; Rahman, NA; Tay, KS, 2009
)
1.08
" Our laboratory bioassays showed that catnip essential oil (at a dosage of 20 mg) resulted in average repellency rates of 96% against stable flies, Stomoxys calcitrans (L."( Efficacy and safety of catnip (Nepeta cataria) as a novel filth fly repellent.
Berkebile, D; DU, HJ; Qian, K; Tong, Y; Zeng, XP; Zhu, JJ, 2009
)
0.35
"when the dosage of essential oils was 5 µL, the cinnamon oil repellent rate was 87."( Repellent activity screening of 11 kinds of essential oils against Aedes albopictus Skuse: microcapsule preparation of Herba Schizonepetae oil and repellent bioassay on hand skin.
Feng, JT; Fu, CC; Ma, ZQ; Wu, H; Yu, DD; Zhang, X, 2013
)
0.39
" The authors' results show that the molecular estrogenic effects of triclocarban are eliminated (males) or reversed (females) when dosed in conjunction with several other PPCP, once again demonstrating that results from single exposures could be vastly different from those observed with mixtures."( Effects of triclocarban, N,N-diethyl-meta-toluamide, and a mixture of pharmaceuticals and personal care products on fathead minnows (Pimephales promelas).
Archuleta, LC; Sanchez, BC; Sepulveda, MS; Zenobio, JE, 2014
)
0.4
" In dose-response tests, the widely used repellents N,N-diethyl-3-methyl benzamide (deet) and 1-methyl-propyl-2-(hydroxyethyl)-1-piperidinecarboxylate (picaridin) were applied to filter paper strips and challenged by ticks at 10, 20, 30, 40, and 120 min after application."( Solvent, drying time, and substrate affect the responses of lone star ticks (Acari: Ixodidae) to the repellents deet and picaridin.
Bedoukian, RH; Carroll, JF; Kramer, M, 2014
)
0.84
" The effects of the treatment conditions, such as chlorine dosage and pH, and the water matrix components of natural organic matter (NOM), alkalinity, ammonia and halides, on the kinetics and reactive species in the degradation of four micropollutants, metronidazole (MDZ), nalidixic acid (NDA), diethyltoluamide (DEET) and caffeine (CAF), by the UV/chlorine process were investigated."( Factors affecting the roles of reactive species in the degradation of micropollutants by the UV/chlorine process.
Chen, L; Fang, J; Guo, K; Hou, S; Kong, X; Meng, F; Shang, C; Wu, Z; Xiao, H; Yang, X, 2017
)
0.63
"Applied dosage is one important variable in determining the persistence of a repellent experienced by users but the maximum concentration in current picaridin formulation is <30%w/v."( Mosquito repellents for the traveller: does picaridin provide longer protection than DEET?
Goodyer, L; Schofield, S, 2018
)
0.7
"Here, we performed IR3535 dose-response analyses on Drosophila melanogaster, a well-known insect model organism, using electrophysiology and binary food choice assays."( Cellular and molecular basis of IR3535 perception in Drosophila.
Lee, Y; Nath, DK; Nhuchhen Pradhan, R; Shrestha, B, 2022
)
0.72
" Dose-response relationships were analyzed using restricted cubic spline regression."( Association of N, N-diethyl-m-toluamide (DEET) with hyperuricemia among adult participants.
Cui, Q; Guan, G; Hui, R; Liu, Z; Wu, R; Xing, Y; Zhang, Y; Zhu, L; Zhu, X, 2023
)
1.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
insect repellentAn insecticide that acts as a repellent to insects.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
benzamides
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (19)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency1.58490.004023.8416100.0000AID485290
Chain A, Ferritin light chainEquus caballus (horse)Potency15.84895.623417.292931.6228AID485281
GLI family zinc finger 3Homo sapiens (human)Potency1.58050.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency0.00170.000221.22318,912.5098AID1259243
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency45.29280.001022.650876.6163AID1224838; AID1224839; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency12.19720.001530.607315,848.9004AID1224848; AID1224849
farnesoid X nuclear receptorHomo sapiens (human)Potency54.39030.375827.485161.6524AID743217
estrogen nuclear receptor alphaHomo sapiens (human)Potency16.59040.000229.305416,493.5996AID743075; AID743077; AID743079
aryl hydrocarbon receptorHomo sapiens (human)Potency60.50940.000723.06741,258.9301AID743085
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency19.62210.001815.663839.8107AID894
chromobox protein homolog 1Homo sapiens (human)Potency89.12510.006026.168889.1251AID540317
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.00790.010039.53711,122.0200AID588545
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency2.98490.000323.4451159.6830AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency0.05450.000627.21521,122.0200AID651741
gemininHomo sapiens (human)Potency0.00520.004611.374133.4983AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency28.69540.005612.367736.1254AID624032
Cellular tumor antigen p53Homo sapiens (human)Potency76.17690.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Odorant binding proteinAnopheles gambiae (African malaria mosquito)Kd31.300031.300031.300031.3000AID977611
Chain B, Odorant binding proteinAnopheles gambiae (African malaria mosquito)Kd31.300031.300031.300031.3000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (127)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1508629Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508627Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508628Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1082376Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 1.6 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1102086Ratio of benzyl benzoate LD50 to compound LD50 for Dermatophagoides pteronyssinus2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1082366Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 13 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1101095Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.02 g/m2 after 24 hr by clip method relative to control2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1103603Acaricidal activity against Dermatophagoides farinae assessed as mortality at 30 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1080481Feeding deterrent activity against Aedes aegypti liverpool assessed as proportion of mosquitoes not biting at 25 nmol/cm2 cloth relative to untreated control2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1082374Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.016 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1103251Acaricidal activity against Dermatophagoides farinae after 24 hr2004Biological & pharmaceutical bulletin, Jun, Volume: 27, Issue:6
Biological activity of alpha-thujaplicin, the isomer of hinokitiol.
AID1102078Acaricidal activity against Dermatophagoides farinae assessed as mortality at 38.2 ug/cm2 after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1101098Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.2 g/m2 after 24 hr by clip method relative to control2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1101094Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.01 g/m2 after 24 hr by clip method relative to control2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1103595Acaricidal activity against Tyrophagus putrescentiae assessed as mortality at 30 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1080480Feeding deterrent activity against Anopheles stephensi assessed as proportion of mosquitoes not biting at 25 nmol/cm2 cloth relative to untreated control2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1102510Insecticidal activity against Tyrophagus putrescentiae assessed as mortality after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1102062Acaricidal activity against Dermatophagoides farinae assessed as mortality at 50.9 ug/cm2 after 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102070Acaricidal activity against Dermatophagoides farinae assessed as mortality at 50.9 ug/cm2 after 48 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1101097Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.1 g/m2 after 24 hr by clip method relative to control2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1082371Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 13 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082378Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.016 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082364Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 3.2 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082381Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 1.6 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1103253Acaricidal activity against Dermatophagoides farinae assessed as mortality at 0.2 g/m'2 after 24 hr relative to control2004Biological & pharmaceutical bulletin, Jun, Volume: 27, Issue:6
Biological activity of alpha-thujaplicin, the isomer of hinokitiol.
AID1103258Acaricidal activity against Dermatophagoides farinae assessed as mortality at 0.5 g/m'2 after 24 hr relative to control2004Biological & pharmaceutical bulletin, Jun, Volume: 27, Issue:6
Biological activity of alpha-thujaplicin, the isomer of hinokitiol.
AID1104348Feeding deterrent activity against freshly molted third-instar larval stage of Trichoplusia ni (cabbage looper) in compound pretreated cabbage leaves at 50 ug/cm2 after 3 to 5 hr by leaf disk choice bioassay2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID1102482Insecticidal activity against Dermatophagoides farinae assessed as mortality at 0.50 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1101100Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 1 g/m2 after 24 hr by clip method relative to control2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1082368Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 1.6 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082373Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.0016 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1102484Insecticidal activity against Dermatophagoides farinae assessed as mortality at 0.10 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1102497Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 1 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1102494Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.20 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1104347Feeding deterrent activity against freshly molted third-instar larval stage of Trichoplusia ni (cabbage looper) in compound pretreated cabbage leaves after 3 to 5 hr by leaf disk choice bioassay2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID1101096Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.05 g/m2 after 24 hr by clip method relative to control2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1103602Acaricidal activity against Dermatophagoides farinae assessed as mortality at 20 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1102088Ratio of benzyl benzoate LD50 to compound LD50 for Dermatophagoides farinae2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102486Insecticidal activity against Dermatophagoides farinae assessed as mortality at 0.20 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1082370Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 6.4 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1103601Acaricidal activity against Dermatophagoides farinae assessed as mortality at 10 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1082363Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 1.6 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082372Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 26 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1102069Acaricidal activity against Dermatophagoides farinae assessed as mortality at 38.2 ug/cm2 after 48 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1102511Insecticidal activity against Dermatophagoides farinae assessed as mortality after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1103257Acaricidal activity against Dermatophagoides farinae assessed as mortality at 0.1 g/m'2 after 24 hr relative to control2004Biological & pharmaceutical bulletin, Jun, Volume: 27, Issue:6
Biological activity of alpha-thujaplicin, the isomer of hinokitiol.
AID1102089Acaricidal activity against Dermatophagoides farinae after 24 hr by fabric disk assay2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1082375Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.16 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1102079Acaricidal activity against Dermatophagoides farinae assessed as mortality at 50.9 ug/cm2 after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1104346Oviposition deterrent activity against adult female Trichoplusia ni (cabbage looper) moths introduced along with male moths into oviposition cage containing compound pretreated cabbage leaves assessed as eggs laying on the leaf disks at 0.25% after 48 hr2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1102490Insecticidal activity against Dermatophagoides farinae assessed as mortality at 1 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1103604Acaricidal activity against Dermatophagoides farinae assessed as mortality at 40 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1102090Acaricidal activity against Dermatophagoides farinae assessed as mortality at 38.2 ug/cm2 after 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1082377Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 16 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082379Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.0016 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1103598Acaricidal activity against Dermatophagoides farinae assessed as mortality after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1103593Acaricidal activity against Tyrophagus putrescentiae assessed as mortality at 10 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1102492Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.50 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1102056Acaricidal activity against Dermatophagoides pteronyssinus assessed as mortality at 38.2 to 50.9 ug/cm2 after 24 to 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1103259Acaricidal activity against Dermatophagoides farinae assessed as mortality at 1 g/m'2 after 24 hr relative to control2004Biological & pharmaceutical bulletin, Jun, Volume: 27, Issue:6
Biological activity of alpha-thujaplicin, the isomer of hinokitiol.
AID1103605Acaricidal activity against Dermatophagoides farinae assessed as mortality at 50 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1103596Acaricidal activity against Tyrophagus putrescentiae assessed as mortality at 50 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1082367Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 26 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1103590Acaricidal activity against Tyrophagus putrescentiae assessed as mortality after 24 hr2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1082380Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.16 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082365Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 6.4 nL/cm2 after 4 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1082382Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 16 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID1102087Acaricidal activity against Dermatophagoides pteronyssinus after 24 hr by fabric disk assay2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1104345Toxicity against third-instar larval stage of Trichoplusia ni (cabbage looper) assessed as mortality at 0.25% after 24 hr by contact toxicity bioassay2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID1101099Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.5 g/m2 after 24 hr by clip method relative to control2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1101093Insecticidal activity against Tyrophagus putrescentiae assessed as mortality after 24 hr by clip method2000Biological & pharmaceutical bulletin, Aug, Volume: 23, Issue:8
Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities.
AID1102493Insecticidal activity against Tyrophagus putrescentiae assessed as mortality at 0.10 g/m'2 after 24 hr by clip method2003Biological & pharmaceutical bulletin, Oct, Volume: 26, Issue:10
Biological activity of tropolone.
AID1103606Acaricidal activity against Tyrophagus putrescentiae assessed as mortality at 100 ug/cm2 after 24 hr relative to control2006Biological & pharmaceutical bulletin, Mar, Volume: 29, Issue:3
Comparison of larvicidal, adulticidal and acaricidal activity of two geometrical butylidenephthalide isomers.
AID1082369Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 3.2 nL/cm2 after 2 hr2011Journal of agricultural and food chemistry, Sep-28, Volume: 59, Issue:18
Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2012Cellular and molecular life sciences : CMLS, Jan, Volume: 69, Issue:2
Anopheles gambiae odorant binding protein crystal complex with the synthetic repellent DEET: implications for structure-based design of novel mosquito repellents.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (907)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990102 (11.25)18.7374
1990's141 (15.55)18.2507
2000's294 (32.41)29.6817
2010's260 (28.67)24.3611
2020's110 (12.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.99 (24.57)
Research Supply Index6.90 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index197.09 (26.88)
Search Engine Supply Index3.74 (0.95)

This Compound (60.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials29 (3.02%)5.53%
Reviews59 (6.15%)6.00%
Case Studies29 (3.02%)4.05%
Observational0 (0.00%)0.25%
Other842 (87.80%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]